Trastuzumab Deruxtecan (T-Dxd; Ds-8201) In Patients With Her2-Low, Advanced Gastric Or Gastroesophageal Junction (Gej) Adenocarcinoma: Results Of The Exploratory Cohorts In The Phase Ii, Multicenter, Open-Label Destiny-Gastric01 Study
Annals of Oncology（2020）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要